Cargando…
Oocyte aging is controlled by mitogen‐activated protein kinase signaling
Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowle...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208789/ https://www.ncbi.nlm.nih.gov/pubmed/34061407 http://dx.doi.org/10.1111/acel.13386 |
_version_ | 1783708991740706816 |
---|---|
author | Achache, Hanna Falk, Roni Lerner, Noam Beatus, Tsevi Tzur, Yonatan B. |
author_facet | Achache, Hanna Falk, Roni Lerner, Noam Beatus, Tsevi Tzur, Yonatan B. |
author_sort | Achache, Hanna |
collection | PubMed |
description | Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowledge regarding reproductive aging in worms and humans is limited. Specifically, little is known about germline internal signals that dictate the oogonial biological clock. Here, we report a thorough characterization of the changes in the worm germline during aging. We found that shortly after ovulation halts, germline proliferation declines, while apoptosis continues, leading to a gradual reduction in germ cell numbers. In late aging stages, we observed that meiotic progression is disturbed and crossover designation and DNA double‐strand break repair decrease. In addition, we detected a decline in the quality of mature oocytes during aging, as reflected by decreasing size and elongation of interhomolog distance, a phenotype also observed in human oocytes. Many of these altered processes were previously attributed to MAPK signaling variations in young worms. In support of this, we observed changes in activation dynamics of MPK‐1 during aging. We therefore tested the hypothesis that MAPK controls oocyte quality in aged worms using both genetic and pharmacological tools. We found that in mutants with high levels of activated MPK‐1, oocyte quality deteriorates more rapidly than in wild‐type worms, whereas reduction of MPK‐1 levels enhances quality. Thus, our data suggest that MAPK signaling controls germline aging and could be used to attenuate the rate of oogenesis quality decline. |
format | Online Article Text |
id | pubmed-8208789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82087892021-06-25 Oocyte aging is controlled by mitogen‐activated protein kinase signaling Achache, Hanna Falk, Roni Lerner, Noam Beatus, Tsevi Tzur, Yonatan B. Aging Cell Original Articles Oogenesis is one of the first processes to fail during aging. In women, most oocytes cannot successfully complete meiotic divisions already during the fourth decade of life. Studies of the nematode Caenorhabditis elegans have uncovered conserved genetic pathways that control lifespan, but our knowledge regarding reproductive aging in worms and humans is limited. Specifically, little is known about germline internal signals that dictate the oogonial biological clock. Here, we report a thorough characterization of the changes in the worm germline during aging. We found that shortly after ovulation halts, germline proliferation declines, while apoptosis continues, leading to a gradual reduction in germ cell numbers. In late aging stages, we observed that meiotic progression is disturbed and crossover designation and DNA double‐strand break repair decrease. In addition, we detected a decline in the quality of mature oocytes during aging, as reflected by decreasing size and elongation of interhomolog distance, a phenotype also observed in human oocytes. Many of these altered processes were previously attributed to MAPK signaling variations in young worms. In support of this, we observed changes in activation dynamics of MPK‐1 during aging. We therefore tested the hypothesis that MAPK controls oocyte quality in aged worms using both genetic and pharmacological tools. We found that in mutants with high levels of activated MPK‐1, oocyte quality deteriorates more rapidly than in wild‐type worms, whereas reduction of MPK‐1 levels enhances quality. Thus, our data suggest that MAPK signaling controls germline aging and could be used to attenuate the rate of oogenesis quality decline. John Wiley and Sons Inc. 2021-06-01 2021-06 /pmc/articles/PMC8208789/ /pubmed/34061407 http://dx.doi.org/10.1111/acel.13386 Text en © 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Achache, Hanna Falk, Roni Lerner, Noam Beatus, Tsevi Tzur, Yonatan B. Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title | Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title_full | Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title_fullStr | Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title_full_unstemmed | Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title_short | Oocyte aging is controlled by mitogen‐activated protein kinase signaling |
title_sort | oocyte aging is controlled by mitogen‐activated protein kinase signaling |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208789/ https://www.ncbi.nlm.nih.gov/pubmed/34061407 http://dx.doi.org/10.1111/acel.13386 |
work_keys_str_mv | AT achachehanna oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling AT falkroni oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling AT lernernoam oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling AT beatustsevi oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling AT tzuryonatanb oocyteagingiscontrolledbymitogenactivatedproteinkinasesignaling |